Cambrex Corp (CBM.N)
CBM.N on New York Stock Exchange
14.40USD
19 Jun 2013
14.40USD
19 Jun 2013
Price Change (% chg)
$-0.36 (-2.44%)
$-0.36 (-2.44%)
Prev Close
$14.76
$14.76
Open
$14.72
$14.72
Day's High
$14.72
$14.72
Day's Low
$14.38
$14.38
Volume
26,900
26,900
Avg. Vol
39,856
39,856
52-wk High
$14.76
$14.76
52-wk Low
$7.57
$7.57
About
Cambrex Corporation (Cambrex) is a life sciences company, which provides products and services, which accelerate and improve the development and commercialization of new and generic therapeutics. The Company’s business is consisted of the custom development and manufacture of pharmaceutical ingredients derived from organic... (more)
Overall
| Beta: | 1.36 |
| Market Cap (Mil.): | $432.46 |
| Shares Outstanding (Mil.): | 30.03 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CBM.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 6.52 | 30.37 | 30.65 |
| EPS (TTM): | 2.21 | -- | -- |
| ROI: | 22.22 | 19.50 | 18.83 |
| ROE: | 47.41 | 20.27 | 19.74 |
Competitors
| Price | Change | |
|---|---|---|
| Albany Molecular Research, Inc. (AMRI.OQ) | $11.76 | -0.21 |
| GeoPharma, Inc. (GORXQ.PK) | $0.01 | -0.00 |
| Natural Alternatives International, Inc. (NAII.OQ) | $4.55 | -0.02 |
| Crucell N.V. (CRCL.AS) | -- | -- |
| Clariant AG (CLN.VX) | CHF13.51 | -0.46 |

Estimates